5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
Dr Seth Wander from Massachusetts General Hospital in Boston discusses recent developments with oral selective estrogen receptor degraders for ER-positive metastatic breast cancer.
You May Also Like
The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories
Dumma Människor
Acast - Lina Thomsgård och Björn Hedensjö
Pädagogik&Pinot
Fea Finger & Sarah Bauer
Podcast de Juan Ramón Rallo
Juan Ramón Rallo
Eye On The Sky
Vermont Public
The Dissenter
Ricardo Lopes
The Feldman Protocol
Dave Feldman
La Science, CQFD
France Culture
Kvantum ideí
Kvantum ideí
Vida Eterna. Respuestas desde la Ciencia | Dr. Manuel Sans Segarra
Dr. Manuel Sans Segarra
The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories
Dumma Människor
Acast - Lina Thomsgård och Björn Hedensjö
Pädagogik&Pinot
Fea Finger & Sarah Bauer
Podcast de Juan Ramón Rallo
Juan Ramón Rallo
Eye On The Sky
Vermont Public
The Dissenter
Ricardo Lopes
The Feldman Protocol
Dave Feldman
La Science, CQFD
France Culture
Kvantum ideí
Kvantum ideí
Vida Eterna. Respuestas desde la Ciencia | Dr. Manuel Sans Segarra
Dr. Manuel Sans Segarra
Community discussion